Deep Tech Startups

HyperLight develops thin-film lithium niobate (TFLN) photonic integrated circuits for high-bandwidth, energy-efficient optical applications in data centers, telecommunications, quantum computing, and AI systems. The company designs, manufactures, and tests TFLN chiplets at scale using semiconductor-compatible processes.

2 investors

HyperSpectral develops a spectral sensing and AI layer for Physical AI that interprets matter through spectral data, molecular identification, and AI architecture. Its work spans applications in life sciences, defense, and enterprise, with experience in FDA regulatory pathways and clinical validation.

2 investors

HyperTunnel develops extended reality (XR) solutions for frontline workers in high-stakes industries including aerospace, defense, manufacturing, and logistics. The platform enables workers to visualize complex data, collaborate intuitively, and perform operational tasks with greater precision through spatial computing and digital twin technologies.

2 investors

Hypetex develops FlaxTex, a coloured natural flax fibre technology that serves as a sustainable, biodegradable alternative to carbon and glass fibre for manufacturing applications. The material is designed for automotive, construction, and consumer product manufacturers seeking lightweight, strong composites with positive environmental credentials.

2 investors

Hefei Ekt Optoelectronics Technology (stock code 688610) develops, manufactures, and sells high-end industrial sensing products, including industrial cameras, frame grabbers, and smart optical units. Its products are used by manufacturers in electronics, displays, semiconductors, lithium batteries, photovoltaics, and life sciences, primarily in China.

2 investors

CHT Group is a speciality chemical manufacturer producing silicone elastomers and rubber compounds for industrial applications including automotive, electronics, and consumer goods. The company operates manufacturing facilities across Germany, Austria, the UK, Italy, North America, and China, serving customers through a global network of offices and partners.

2 investors

iCorNet develops a tailored cardiac remodeling prevention net using 3D cardiac imaging and computer-controlled knitting technology to treat dilated cardiomyopathy. The device is designed for heart failure patients who do not respond adequately to drug therapy and cannot access cardiac transplantation.

2 investors

ID Quantique develops quantum technologies for cybersecurity, quantum networking, and sensing applications. The company provides quantum-safe communication systems, single-photon generation and detection devices, and quantum internet infrastructure for enterprises, governments, and research institutions.

2 investors

Idealab is a technology incubator that generates startup ideas internally, tests many in parallel, and spins the most promising into standalone companies with recruited teams. Founded in 1996, it has created 145+ companies with more than 45 IPOs and acquisitions.

2 investors

IDUN Technologies develops brain-computer interface devices that collect and process cognitive and emotional data to promote wellbeing. The company serves research institutions and commercial partners applying neurotechnology for observation, diagnosis, intervention, and wellness applications.

2 investors

Iiwari is a Finnish technology company that develops indoor positioning and location-based tracking systems, built on research from the VTT research institute and multiple patents. Its solutions serve businesses in sectors such as healthcare and manufacturing, including nurse-alert and safety systems for nursing homes and hospitals as well as tool and process tracking in industrial settings.

2 investors

Spaya is an AI-powered retrosynthesis platform that identifies synthetic routes to target compounds by converting them into commercially available starting materials. It serves chemists and drug discovery teams seeking to accelerate research through rapid, customizable synthesis planning.

2 investors

ILC Therapeutics is a biotechnology company developing hybrid interferon therapeutics, including its Alfacyte product, based on an interferon platform. The company operates in the drug development and pharmaceutical industry.

2 investors

Illumina Ventures is a venture capital firm focused on genomics and precision health, investing in early-stage companies developing breakthrough science and technology to improve human health. The firm provides capital, sequencing access, mentorship, and lab capabilities to portfolio companies through its Labs program.

2 investors

ImagoAI develops rapid food safety and quality testing solutions using hyperspectral imaging combined with AI for the food industry. The company targets on-site testing needs, particularly for detecting mycotoxins and other contaminants in food supply chains.

2 investors

Autonomous driving software company that develops AI-based, camera-centric self-driving technology for public transportation vehicles. The company partners with bus manufacturers and fleet operators to integrate autonomous solutions into buses and vans without requiring HD-maps or cloud infrastructure.

2 investors

Immersion builds a neuroscience-based platform that measures human connection and engagement, helping users turn emotional-response data into insights. It is aimed at those seeking to understand and strengthen connection on a deeper level.

2 investors

Immunito AI is an in-silico antibody discovery company that combines artificial intelligence with an in-house biological lab to speed up and improve the discovery of antibodies. It serves the biotech and biopharmaceutical industry.

2 investors

NapaJen Pharma is a biopharmaceutical research and development company developing nucleic acid (oligonucleotide) drugs using a proprietary cell-specific drug delivery platform that enables delivery to immune cells for precision-targeted immunosuppression and controlled immuno-stimulation. It develops its own drug candidates and partners with other pharmaceutical companies applying its delivery technology.

2 investors

ImmunoVec develops programmable DNA-based in vivo medicines that use cell type- and cell state-specific synthetic promoters to control payload expression in targeted cells for treating cancer and autoimmune disease. Its expression cassettes can be incorporated into both viral and non-viral delivery vehicles such as lentivirus, AAV, lipid and polymeric nanoparticles, and exosomes.

2 investors

Inaedis develops RTAD (Room Temperature Ambient Drying), a biopharmaceutical formulation platform that enables alternative drug delivery routes for monoclonal antibodies and biologics, including subcutaneous, inhaled, and intranasal administration. The platform reduces manufacturing risk and cost for pharmaceutical companies while improving patient access through room-temperature stability and simplified administration.

2 investors

Indi Molecular develops small-molecule oncology therapeutics based on protein-catalyzed capture agents (PCCs) created through click chemistry, a synthetic process developed in collaboration with Caltech. The company focuses on drug candidates targeting ovarian and pancreatic cancer.

2 investors

Inductosense designs and manufactures ultrasonic sensor technologies for internal corrosion and erosion monitoring in industrial assets. The company provides the WAND product line, an embeddable wall thickness monitoring system that enables cost-effective and repeatable measurements for customers in oil, gas, and related sectors globally.

2 investors

Infiniplex is a precision oncology company developing InfiniplexDX, a liquid biopsy platform that uses proprietary primer design and molecular-switch chemistry with software-based signal analysis to detect cancer mutations in blood and urine on standard PCR instruments. It targets five clinical indications (bladder cancer, myelodysplastic syndromes, pancreatic, colorectal, and non-small cell lung cancer) to support treatment decisions without tissue biopsies.

2 investors